Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Chemical Research in Toxicology
|
February 22, 2011
Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes
Eyal Drug, Dalit Landesman-Milo, Bogdan Belgorodsky, et al.
Plos One
|
November 19, 2010
Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Nirit Egoz-Matia, et al.
Parkinson'S Disease
|
August 14, 2012
A novel, sensitive assay for behavioral defects in Parkinson's disease model Drosophila
Ronit Shaltiel-Karyo, Dan Davidi, Yotam Menuchin, et al.
Journal of Alzheimer'S Disease : JAD
|
February 3, 2016
Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity
Moran Frenkel-Pinter, Sharon Tal, Roni Scherzer-Attali, et al.
Neuro-Degenerative Diseases
|
October 21, 2016
Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity
Moran Frenkel-Pinter, Sharon Tal, Roni Scherzer-Attali, et al.
Nature Communications
|
May 13, 2022
Thioesters provide a plausible prebiotic path to proto-peptides
Moran Frenkel-Pinter, Marcos Bouza, Facundo M Fernández, et al.
Life (Basel, Switzerland)
|
February 25, 2022
Differential Oligomerization of Alpha versus Beta Amino Acids and Hydroxy Acids in Abiotic Proto-Peptide Synthesis Reactions
Moran Frenkel-Pinter, Kaitlin C Jacobson, Jonathan Eskew-Martin, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 14, 2020
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration
Yelena Losev, Moran Frenkel-Pinter, Malak Abu-Hussien, et al.
Neurobiology of Aging
|
May 30, 2017
Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila
Moran Frenkel-Pinter, Shiri Stempler, Sharon Tal-Mazaki, et al.
The Journal of Biological Chemistry
|
May 3, 2013
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Chemical Research in Toxicology
|
February 22, 2011
Enhanced bioavailability of polyaromatic hydrocarbons in the form of mucin complexes
Eyal Drug, Dalit Landesman-Milo, Bogdan Belgorodsky, et al.
Plos One
|
November 19, 2010
Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Nirit Egoz-Matia, et al.
Parkinson'S Disease
|
August 14, 2012
A novel, sensitive assay for behavioral defects in Parkinson's disease model Drosophila
Ronit Shaltiel-Karyo, Dan Davidi, Yotam Menuchin, et al.
Journal of Alzheimer'S Disease : JAD
|
February 3, 2016
Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity
Moran Frenkel-Pinter, Sharon Tal, Roni Scherzer-Attali, et al.
Neuro-Degenerative Diseases
|
October 21, 2016
Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity
Moran Frenkel-Pinter, Sharon Tal, Roni Scherzer-Attali, et al.
Nature Communications
|
May 13, 2022
Thioesters provide a plausible prebiotic path to proto-peptides
Moran Frenkel-Pinter, Marcos Bouza, Facundo M Fernández, et al.
Life (Basel, Switzerland)
|
February 25, 2022
Differential Oligomerization of Alpha versus Beta Amino Acids and Hydroxy Acids in Abiotic Proto-Peptide Synthesis Reactions
Moran Frenkel-Pinter, Kaitlin C Jacobson, Jonathan Eskew-Martin, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 14, 2020
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration
Yelena Losev, Moran Frenkel-Pinter, Malak Abu-Hussien, et al.
Neurobiology of Aging
|
May 30, 2017
Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila
Moran Frenkel-Pinter, Shiri Stempler, Sharon Tal-Mazaki, et al.
The Journal of Biological Chemistry
|
May 3, 2013
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein, et al.
Page
of 4